LINDSEY MCCRARY: Open Payments
NPI 1043834567 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 57 payments from 18 companies in 2025. Trend: 2023 $758 · 2024 $1,149 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $173 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| GlaxoSmithKline, LLC. | 11 | $159 |
| Lilly USA, LLC | 5 | $115 |
| Novo Nordisk Inc | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| ABBVIE INC. | 3 | $63 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
Products named: Auvelity, TRELEGY ELLIPTA, MOUNJARO, FARXIGA, AIRSUPRA, Wegovy, Kerendia, Quviviq.
Industry payments across TX — which companies pay providers there.
